Epidemiology of thyroid cancer;Epidemiologie des schilddrüsenkarzinoms

Onkologe

Volumn 11, Issue 1, 2005, Pages 11-19

  Reiners, Chr ^a,b   Geling, M ^a   Luster, M ^a   Farahati, J ^a   Mader U ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Nutritional iodine supply; Prognosis; Radiation exposure in childhood; Thyroid cancer

Indexed keywords

IODINE;

ANAPLASTIC CARCINOMA; ARTICLE; AUTOPSY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SURVIVAL; FOLLICULAR CARCINOMA; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; METASTASIS; PAPILLARY CARCINOMA; PROGNOSIS; RADIATION EXPOSURE; SURVIVAL RATE; SURVIVAL TIME; THYROID CARCINOMA; TUMOR GROWTH;

EID: 13644263310     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-004-0813-1     Document Type: Article

References (29)

1. Bertz J, Hentschel S, Hundsdörfer G, Kaatsch P, Katalinic A, Lehnert M, Schön D, Stegmaier C, Ziegler H (2004) Krebs in Deutschland, 4. überarbeitete, aktualisierte Ausgabe. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland in Zusammenarbeit mit dem Robert-Koch-Institut, Saarbrücken
2. Biermann M, Schober O (2005) Radioiodtherapie des Schilddrü senkarzinoms. Der Onkologe/Heft 1, s00761-004-0814-0
3. Busnardo B, De Vido D (2000) The epidemiology and etiology of differentiated thyroid carcinoma. Biomed Pharmacother 54:322-326
4. Dralle H, Machens A, Brauckhoff M, Ukkat J, Sekulla C, Nguyen Thanh P, Lorenz K, Grimm O (2005) Chirurgie der Schilddrüsenkarzinorme: Sollten nach Einführung der neuen TNM-Klassifikation die chirurgischen Leitlinien geändert werden? Der Onkologe/Heft 1, s00761-004-0809-x
5. Cady B, Rossi R (1988) An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 104:947-953
6. Eichhorn W, Tabler H, Lippold R, Lochmann M, Schreckenberger M, Bartenstein P (2003) Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution. Thyroid 13:949-958
7. Farahati J, Geling M, Mäder U, Mörtl M, Luster M, Müller JG, Flentje M, Reiners Chr (2004) Changing Trends of Incidence and Prognosis of Thyroid Carcinoma in Lower Franconia, Germany, from 1981-1995. Thyroid 14:141-147
8. Feldt-Rasmussen U (2001) Iodine and cancer. Thyroid 11:483-186
9. Franceschi S, Boyle P, Maisonneuve P, La Vecchia C, Burt AD, Kerr DJ, MacFarlane GJ (1993) The epidemiology of thyroid carcinoma. Crit Rev in Oncogen 4:25-52
10. Gilliland FD, Hunt WC, Morris DM et al. (1997) Prognostic factors for thyroid carcinoma. A population based study of 15.698 cases from the Surveillance Epidemiology and End Results (SEER) program 1973-1991. Cancer 79:564-573
11. Hay ID, Bergstrahl EJ, Goellner JR et al. (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1057
12. Hay ID, Grant CS, Taylor WF et al. (1987) Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1095
13. Hölzer S, Reiners Chr, Mann K et al. (2000) Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. US and German Thyroid Cancer Group. Cancer 89:192-201
14. Hundahl SA, Fleming ID, Fremgen AG et al. (1998) A national cancer data base report on 53.856 cases of thyroid carcinoma treated in the U.S. 1985-1995. Cancer 83:1238-2648
15. Karges W (2005) Klinische und molekulare Genetik des Schilddrü senkarzinoms. Der Onkologe/Heft 1, s00761-004-0812-2
16. Körber C, Geling M, Werner E, Mörtl M, Mäder U, Reiners C, Farahati J (2000) Incidence of the Familial Non-medullary Thyroid Carcinoma in the Patient Register of the Clinic and Policlinic of Nuclear Medicine, University of Wuerzburg. Nuklearmedizin 39:16-21
17. Lerch H, Schober O, Kuwert T, Saur HB (1997) Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15:2067-75
18. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J (1992) Cancer incidence in five continents. International Agency for Research on Cancer, Lyon (France)
19. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A (2004) Clinical behaviour and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89:3713-20
20. Raue F (2005) Diagnostik des Schilddrüsenkarzinoms. Der Onkologe/Heft 1, s00761-004-0816-y
21. Reiners Chr, Biko J, Demidchik EP, Drozd V (2000) Thyroid cancer after exposure to ionizing irradiation: histology, staging and clinical data. In: Peter F, Wiersinga W, Hostalek U eds. The Thyroid and Environment. Stuttgart, New York: Schattauer, 193-204
22. Reiners Chr (2003) Diagnostik, Therapie und Nachsorge des Schilddrüsenkarzinoms. UniMed, Bremen London Boston
23. Reiners Chr, Mäder U, Geling M, Luster M, Farahati J (2003) Epidemiologie des Schilddrüsenkarzinoms bei veränderter lodversorgung. In: Schilddrüse 2003. de Gruyter, Berlin New York, S 185-189
24. Ron E, Lublin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD (1995) Thyroid Cancer after exposure to external radiation: a pooled analysis of seven studies. Rad Research 141:259-277
25. Schlumberger MK (1998) Papillary and follicular thyroid carcinoma. New Engl J Med 338:297-306
26. Schmid KW, Sheu SY, Tötsch M, Görges R, Bockisch A, Mann K (2005) Pathologie des Schilddrüsenkarzinoms. Der Onkologe/Heft 1 (im Druck)
27. Surveillance, Epidemiology and End Results (SEER) Program (April 2003) National Cancer Institute, Cancer Statistics Branch (www.seer.cancer.gov)
28. th en. Springer, Berlin Heidelberg New York
29. Vini L, Hyer SL, Marshall J, A'Hern R, Harmer C (2003) Long-term results in elderly patients with differentiated thyroid carcinoma. Cancer 97:2736-2742